Vendrell J P, Reynes J, Huguet M F, Ngou J, Michard C, Atoui N, Pratlong F, Segondy M, Serre A
Department of Immunology, INSERM unit 249, Institut de Biologie, Montpellier, France.
Lancet. 1993 Jul 3;342(8862):22-3. doi: 10.1016/0140-6736(93)91883-n.
Toxoplasma-specific in-vitro antibody production by peripheral blood lymphocytes (PBL) was investigated in 124 adults infected with human immunodeficiency virus (HIV-1). PBL from 20 of 21 patients with cerebral toxoplasmosis showed spontaneous in-vitro secretion of antibodies to Toxoplasma gondii antigens. Among 103 HIV-1-infected patients without signs or symptoms of toxoplasmosis, PBL from 19 produced toxoplasma-specific antibodies in vitro; 5 of these patients, who discontinued prophylaxis for toxoplasmic encephalitis, showed in-vitro antibody production 3-15 months before the diagnosis of toxoplasmic encephalitis. In-vitro production of toxoplasma-specific antibodies could improve the diagnosis of toxoplasmic encephalitis in HIV-1-infected patients.
对124例感染人类免疫缺陷病毒(HIV-1)的成年人外周血淋巴细胞(PBL)产生弓形虫特异性体外抗体的情况进行了研究。21例脑弓形虫病患者中有20例的PBL显示出体外自发分泌抗刚地弓形虫抗原的抗体。在103例无弓形虫病体征或症状的HIV-1感染患者中,有19例的PBL在体外产生了弓形虫特异性抗体;其中5例停止弓形虫性脑炎预防治疗的患者,在诊断为弓形虫性脑炎前3 - 15个月显示出体外抗体产生。体外产生弓形虫特异性抗体可能会改善HIV-1感染患者弓形虫性脑炎的诊断。